Facial hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib. [electronic resource]
Producer: 20100805Description: e56-8 p. digitalISSN:- 1097-6787
- Adenocarcinoma -- drug therapy
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Eyelashes
- Face
- Female
- Humans
- Hypertrichosis -- chemically induced
- Lung Neoplasms -- drug therapy
- Middle Aged
- Protein Kinase Inhibitors -- adverse effects
- Quinazolines -- adverse effects
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.